Showing results (91-100 of 202) with videos related to
Sort By:
Pageof 21
Blood Advances|February 24, 2026
Predictive capacity of peritransplant measurable residual disease thresholds in NPM1-mutant acute myeloid leukemiaJan Christian Schroeder, Friederike Schwartz, Judith Metzdorf, et al.Annals of the New York Academy of Sciences|June 17, 2005
Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia veraUlrich Steidl, Thomas Schroeder, Christian Steidl, et al.ACS Applied Materials & Interfaces|April 15, 2015
Imaging Structure and Composition Homogeneity of 300 mm SiGe Virtual Substrates for Advanced CMOS Applications by Scanning X-ray Diffraction MicroscopyMarvin H Zoellner, Marie-Ingrid Richard, Gilbert A Chahine, et al.Sensors (Basel, Switzerland)|August 23, 2020
First Evaluation of PRISMA Level 1 Data for Water ApplicationsClaudia Giardino, Mariano Bresciani, Federica Braga, et al.Cancers|June 19, 2024
Overlapping Stromal Alterations in Myeloid and Lymphoid NeoplasmsLucienne Bogun, Annemarie Koch, Bo Scherer, et al.Leukemia Research|May 14, 2021
Eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral centerKathrin Nachtkamp, Josefine Stark, Andrea Kündgen, et al.Blood Advances|January 20, 2022
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosisNico Gagelmann, Christine Wolschke, Rachel B Salit, et al.Bone Marrow Transplantation|April 24, 2025
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in active disease: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSara Tarantino, Myriam Labopin, Robert Zeiser, et al.Haematologica|December 5, 2024
Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell TherapyWolfgang Bethge, Sarah Flossdorf, Franziska Hanke, et al.Oncotarget|July 3, 2018
Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literatureAndrea Kuendgen, Catharina Müller-Thomas, Michael Lauseker, et al.Pageof 21